Search Results

You are looking at 81 - 90 of 102 items for :

  • Refine by Access: Content accessible to me x
Clear All

) reported on the efficacy of MDMA and psilocybin in treating symptoms of PTSD and depression, but noted that confounders, patient bias, and challenges associated with blinding remain. Recent articles provide a valuable analysis of methodological problems

Open access

“relive the drug taking experience in their imagination” ( Baumann, 1970 , p. 20) with similar findings indicated more recently in a group of 3,4-Methylenedioxymethamphetamine (MDMA) users ( Hastings, 2006 ) suggesting the re-accessing of psychedelic

Open access

, E. , & Marcela Ot’alora , G. ( 2013 ). A manual for MDMA-assisted psychotherapy in the treatment of posttraumatic stress disorder . Priest , G. , Tanaka , K. , & Weber , Z. ( 1996 ). Paraconsistent logic . Roseman , L. , Nutt , D. J

Open access

-drug interactions between psychiatric medications and MDMA or psilocybin: A systematic review . Psychopharmacology , 239 , 1945 – 1976 . https://doi.org/10.1007/s00213-022-06083-y . 10.1007/s00213-022-06083-y

Open access
Journal of Psychedelic Studies
Authors:
Avery Sapoznikow
,
Zachary Walsh
,
Kenneth W. Tupper
,
Earth Erowid
, and
Fire Erowid

. S. , & Brewerton , T. D. ( 2016 ). Novel psychopharmacological therapies for psychiatric disorders: Psilocybin and MDMA . The Lancet Psychiatry, 3 ( 5 ), 481 – 488 . doi: 10.1016/S2215-0366(15)00576-3 10.1016/S2215

Open access

-site crossover study to assess psychological effects of MDMA when administered to healthy volunteers . Retrieved 28 June 2020 from https://mapscontent.s3-us-west-1.amazonaws.com/pdfs/MT1+Santized+for+Website+Protocol+A5V2+Clean+08APR2020.pdf . Muthukumaraswamy

Open access

Introduction: pharmacovigilance beyond the individual level? In December 2023 the Multidisciplinary Association for Psychedelic Studies submitted a new drug application to the Food & Drug Administration for the use of MDMA in the treatment of post

Open access
Journal of Psychedelic Studies
Authors:
Eduardo Ekman Schenberg
,
Maria Angélica de Castro Comis
,
João Felipe Morel Alexandre
,
Luís Fernando Tófoli
,
Bruno Daniel Rasmussen Chaves
, and
Dartiu Xavier da Silveira

for one patient each. Other substances mentioned by some patients included “acid” [lysergic acid diethylamide (LSD)], “ecstasy” [3,4-methylenedioxymethamphetamine (MDMA)], mushrooms, solvents/inhalants, and amphetamines. Only one patient had previous

Open access

-B [2,5-dimethoxy-4-bromophenethylamine] etc.), 5-MeO-DMT (5-methoxy- N,N -dimethyltryptamine), Ayahuasca (or analogues), smoked DMT ( N,N -Dimethyltryptamine), LSD (Lysergic acid diethylamide), MDMA (3,4-Methylenedioxy-methamphetamine), Mescaline

Open access

among MDMA and other drug users . Drug and Alcohol Dependence , 96 ( 1–2 ), 99 – 110 . 10.1016/j.drugalcdep.2008.02.003 Han , X. , Wu , X. , Wang , Y. , Sun , Y. , Ding , W. , Cao , M. , ( 2018 ). Alterations of resting-state static and

Open access